Jerome Stevens Pharmaceuticals


Jerome Stevens Pharmaceuticals, Inc. is dedicated to manufacturing and providing pharmaceutical products, including Unithroid and Levothyroxine, with a focus on quality control and innovation. The company actively engages in sponsorship campaigns to support educational and community initiatives.

Industries

biotechnology
health-care
manufacturing
pharmaceutical

Nr. of Employees

medium (51-250)

Jerome Stevens Pharmaceuticals

60 Davinci Drive, Bohemia, NY, 11716, United States


Patents

Sustained drug release and improved product stability using non-covalent particle coating methods

US-9526701-B2

View Details

Products

Levothyroxine sodium oral solution (acquired product)

An oral solution formulation of levothyroxine intended as a finished pharmaceutical product.

Levothyroxine finished product (commercial supply)

Finished pharmaceutical levothyroxine product(s) supplied under commercial agreements and through distribution channels.


Services

Provision of licensing and long-term supply agreements to distribute pharmaceutical products.

Operational production, quality control testing, and packaging services for pharmaceutical products.

Expertise Areas

  • Pharmaceutical manufacturing and supply
  • Thyroid hormone product portfolio management
  • Commercial licensing and supply agreements
  • Quality control and packaging for pharmaceuticals
  • Show More (1)

Key Technologies

  • Oral liquid (solution) pharmaceutical formulation
  • Small-molecule pharmaceutical manufacturing processes
  • Supply chain and distribution systems for pharmaceuticals
  • Quality control testing workflows

News & Updates

A news article about a licensing and supply agreement involving Jerome Stevens Pharmaceuticals.

An article discussing the company's supply status regarding Levoxyl.

A news piece about the company's acquisition of Thyquidity levothyroxine sodium oral solution.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.